A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

Withdrawn

• Conditions: Cancer
• Interventions: Other: IPTLD and nutrition therapy

• Registration Number: NCT02598479
• Lead Sponsor: Best Answer for Cancer Foundation

Brief Summary

The IPTLD QoL Broad Study.

Detailed Description

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.

Study Timeline

• Study Start: 2015-11
• Study First Submitted: 2015-11-04
• Study First Submitted QC: 2015-11-04
• Study First Posted: 2015-11-06
• Status Verified: 2018-08
• Primary Completion: 2018-08
• Study Completion: 2018-08
• Last Update Submitted: 2018-08-27
• Last Update Posted: 2018-08-28

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• diagnosis of cancer,
• age older than 18 years,
• requesting IPTLD and nutrition therapy

Exclusion Criteria

• diagnosis other than cancer,
• age younger than 18 years,
• requesting conventional chemotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
IPTLD and nutrition therapy	IPTLD and nutrition therapy	Patients presenting to the Arizona Center for Advanced Medicine for the treatment of cancer using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy

Primary Outcome Measures

Name	Time	Method
Improvement in Quality of Life measured by questionnaires	5 years	Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires

Trial Locations

Locations (1)

Arizona Center for Advanced Medicine; 🇺🇸 Scottsdale, Arizona, United States